WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017193134) MESENCHYMAL STEM CELL PROLIFERATION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2017/193134    International Application No.:    PCT/US2017/031585
Publication Date: 09.11.2017 International Filing Date: 08.05.2017
Chapter 2 Demand Filed:    06.03.2018    
IPC:
C07K 14/75 (2006.01), C12N 5/0775 (2010.01), A61K 38/36 (2006.01), A61K 38/18 (2006.01), A61K 35/28 (2015.01), A61L 27/54 (2006.01)
Applicants: LACERTA TECHNOLOGIES INC. [US/US]; 176 Mine Lake Court Suite 100 Raleigh, North Carolina 27616-6417 (US)
Inventors: SIMON, Melinda; (HU).
HORNYÁK, István; (AT).
LACZA, Zsombor; (HU)
Agent: VOIGHT, Jason; (US)
Priority Data:
P1600306 06.05.2016 HU
Title (EN) MESENCHYMAL STEM CELL PROLIFERATION
(FR) PROLIFÉRATION DE CELLULES SOUCHES MÉSENCHYMATEUSES
Abstract: front page image
(EN)The invention relates to a use of serum fraction of platelet rich fibrin (SPRF) for increasing mesenchymal stem cell (MSC) proliferation rate wherein said differentiated MSCs maintain their potential to differentiate in several cell types. The invention also relates to SPRF for use in therapy, wherein in said therapy SPRF obtained from a donor subject used to increase proliferation rate of the patients MSCs.
(FR)L'invention concerne l'utilisation d'une fraction sérique de fibrine riche en plaquettes (SPRF) pour augmenter le taux de prolifération des cellules souches mésenchymateuses (MSC), lesdites MSC différenciées maintenant leur potentiel à se différencier en plusieurs types de cellules. L'invention concerne également une SPRF destinée à être utilisée en thérapie, dans ladite thérapie par SPRF obtenue à partir d'un sujet donneur étant destinée à augmenter le taux de prolifération des MSC du patient.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)